The FDA has issued a warning and recall for Hologic Inc.’s BioZorb Marker products, implantable devices used for marking soft tissues. This follows reports of serious adverse events, including pain, infection, and device migration. The recall mandates the return of all unused BioZorb devices and advises healthcare providers on managing existing implants.